Genomic analysis of left ventricular remodeling
R Sarwar, SA Cook - Circulation, 2009 - Am Heart Assoc
hemodynamic parameters correlate poorly with LVM in humans3, 33, 34 and the rat. 35–37
Although limited, there are compelling examples of genes that have been identified through …
Although limited, there are compelling examples of genes that have been identified through …
Gene expression analysis to identify mechanisms underlying heart failure susceptibility in mice and humans
C Koentges, ME Pepin, C Müsse, K Pfeil… - Basic research in …, 2018 - Springer
Genetic factors are known to modulate cardiac susceptibility to ventricular hypertrophy and
failure. To determine how strain influences the transcriptional response to pressure overload …
failure. To determine how strain influences the transcriptional response to pressure overload …
Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling
T Oka, J Xu, RA Kaiser, J Melendez… - Circulation …, 2007 - Am Heart Assoc
The cardiac extracellular matrix is a dynamic structural support network that is both
influenced by, and a regulator of, pathological remodeling and hypertrophic growth. In …
influenced by, and a regulator of, pathological remodeling and hypertrophic growth. In …
Genetic manipulation of periostin expression in the heart does not affect myocyte content, cell cycle activity, or cardiac repair
Following a pathological insult, the adult mammalian heart undergoes hypertrophic growth
and remodeling of the extracellular matrix. Although a small subpopulation of …
and remodeling of the extracellular matrix. Although a small subpopulation of …
Periostin reexpression in heart disease contributes to cardiac interstitial remodeling by supporting the cardiac myofibroblast phenotype
Cardiac muscle (the myocardium) is a unique arrangement of atria and ventricles that are
spatially and electrically separated by a fibrous border. The spirally-arranged myocytes in …
spatially and electrically separated by a fibrous border. The spirally-arranged myocytes in …
Periostin paves the way for neonatal heart regeneration
JE Hudson, ER Porrello - Cardiovascular Research, 2017 - academic.oup.com
The adult mammalian heart has a low intrinsic capacity for regeneration following damage.
As a consequence, myocardial infarction (MI) results in substantial myocyte loss, which is …
As a consequence, myocardial infarction (MI) results in substantial myocyte loss, which is …
[HTML][HTML] Defining the timeline of periostin upregulation in cardiac fibrosis following acute myocardial infarction in mice
H Gil, M Goldshtein, S Etzion, S Elyagon, U Hadad… - Scientific Reports, 2022 - nature.com
After myocardial infarction (MI), the heart's reparative response to the ischemic insult and the
related loss of cardiomyocytes involves cardiac fibrosis, in which the damaged tissue is …
related loss of cardiomyocytes involves cardiac fibrosis, in which the damaged tissue is …
[HTML][HTML] Periostin expression is upregulated and associated with myocardial fibrosis in human failing hearts
S Zhao, H Wu, W Xia, X Chen, S Zhu, S Zhang… - Journal of …, 2014 - Elsevier
Background and purpose Periostin, a matricellular protein, plays an important role in cardiac
development and remodeling. Its expression profile and the association with myocardial …
development and remodeling. Its expression profile and the association with myocardial …
Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair
B Kühn, F Del Monte, RJ Hajjar, YS Chang… - Nature medicine, 2007 - nature.com
Adult mammalian hearts respond to injury with scar formation and not with cardiomyocyte
proliferation, the cellular basis of regeneration. Although cardiogenic progenitor cells may …
proliferation, the cellular basis of regeneration. Although cardiogenic progenitor cells may …
Periostin is a novel factor in cardiac remodeling after experimental and clinical unloading of the failing heart
WE Stansfield, NM Andersen, RH Tang… - The Annals of thoracic …, 2009 - Elsevier
BACKGROUND: Maladaptive left ventricular hypertrophy (LVH) remains a prevalent and
highly morbid condition associated with end-stage heart disease. Originally evaluated in the …
highly morbid condition associated with end-stage heart disease. Originally evaluated in the …